Benign Hepatocellular Tumors

Practical Hepatic Pathology

Volumn , Issue , 2011, Pages 473-488

  Bioulac Sage, Paulette ^a   Laumonier, Hervé ^b   Balabaud, Charles Paul ^c  

^a HÔPITAL PELLEGRIN   (France)

^b HÔPITAL SAINT ANDRÉ   (France)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79958832750     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-06803-4.00034-4     Document Type: Chapter

References (16)

1. Rebouissou S., Bioulac-Sage P., Zucman-Rossi J. Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol. 2008, 48:163-170.
2. Terkivatan T., van den Bos I.C., Hussain S.M., et al. Focal nodular hyperplasia: Lesion characteristics on state-of-the-art MRI including dynamic gadolinium-enhanced and superparamagnetic iron-oxide-uptake sequences in a prospective study. J Magn Reson Imaging. 2006, 24:864-872.
3. Brancatelli G., Federle M.P., Vullierme M.P., et al. CT and MR imaging evaluation of hepatic adenoma. J Comput Assist Tomogr. 2006, 30:745-750.
4. Laumonier H., Bioulac-Sage P., Laurent C., et al. Hepatocellular adenomas: Magnetic resonance imaging features as a function of molecular pathological classification. Hepatology. 2008, 48:808-818.
5. Kim T.K., Jang H.J., Burns P.N., et al. Focal nodular hyperplasia and hepatic adenoma: Differentiation with low-mechanical-index contrast-enhanced sonography. AJR Am J Roentgenol. 2008, 190:58-66.
6. Bioulac-Sage P., Laumonier H., Rullier A., et al. Over-expression of glutamine synthetase in focal nodular hyperplasia: A novel easy diagnostic tool in surgical pathology. Liver Int. 2009, 29:459-465.
7. Zucman-Rossi J., Jeannot E., Nhieu J.T., et al. Genotype-phenotype correlation in hepatocellular adenoma: New classification and relationship with HCC. Hepatology. 2006, 43:515-524.
8. Bioulac-Sage P., Rebouissou S., Thomas C., et al. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Hepatology. 2007, 46:740-748.
9. Bacq Y., Jacquemin E., Balabaud C., et al. Familial liver adenomatosis associated with hepatocyte nuclear factor 1alpha inactivation. Gastroenterology. 2003, 125:1470-1475.
10. Bioulac-Sage P., Rebouissou S., Sa Cunha A., et al. Clinical, morphologic, and molecular features defining so-called telangiectatic focal nodular hyperplasias of the liver. Gastroenterology. 2005, 128:1211-1218.
11. Rebouissou S., Amessou M., Couchy G., et al. Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumours. Nature. 2009, 457:200-204.
12. Paradis V., Laurent A., Flejou J.F., et al. Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology. 1997, 26:891-895.
13. Rebouissou S., Couchy G., Libbrecht L., et al. The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol. 2008, 49:61-71.
14. Bluteau O., Jeannot E., Bioulac-Sage P., et al. Bi-allelic inactivation of TCF1 in hepatic adenomas. Nat Genet. 2002, 32:312-315.
15. Jeannot E., Poussin K., Chiche L., et al. Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma. Cancer Res. 2007, 67:2611-2616.
16. Toso C., Majno P., Andres A., et al. Management of hepatocellular adenoma: Solitary-uncomplicated, multiple and ruptured tumors. World J Gastroenterol. 2005, 11:5691-5695.